Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Precision Medicine and Metabolic Syndrome Publisher



Gharipour M1 ; Nezafati P2 ; Sadeghian L1 ; Eftekhari A3 ; Rothenberg I4 ; Jahanfar S5
Authors
Show Affiliations
Authors Affiliations
  1. 1. Isfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Cardiac Rehabilitation Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
  3. 3. Hypertension Research Center, Cardiovascular Research Institute, Isfahan University of Medicine Sciences, Isfahan, Iran
  4. 4. Laboratory Quality Advisor/Technical Writer at COLA Resources Inc., Columbia, WA, United States
  5. 5. Health Sciences Building, Central Michigan University, Mount Pleasant, MI, United States

Source: ARYA Atherosclerosis Published:2022


Abstract

Metabolic syndrome (MetS) is one of the most important health issues around the world and a major risk factor for both type 2 diabetes mellitus (T2DM) and cardiovascular diseases. The etiology of MetS is determined by the interaction between genetic and environmental factors. Effective prevention and treatment of MetS notably decreases the risk of its complications such as diabetes, obesity, hypertension, and dyslipidemia. According to recent genome-wide association studies, multiple genes are involved in the incidence and development of MetS. The presence of particular genes which are responsible for obesity and lipid metabolism, affecting insulin sensitivity and blood pressure, as well as genes associated with inflammation, can increase the risk of MetS. These molecular markers, together with clinical data and findings from proteomic, metabolomic, pharmacokinetic, and other methods, would clarify the etiology and pathophysiology of MetS and facilitate the development of personalized approaches to the management of MetS. The application of personalized medicinebased on susceptibility identified genomes would help physicians recommend healthier lifestyles and prescribe medications to improve various aspects of health in patients with MetS. In recent years, personalized medicine by genetic testing has helped physicians determine genetic predisposition to MetS, prevent the disease by behavioral, lifestyle-related, or therapeutic interventions, and detect, diagnose, treat, and manage the disease. Clinically, personalized medicine is providing effective strategies for the prevention and treatment of MetS by reducing the time, cost, and failure rate of pharmaceutical clinical trials. It is also eliminating trial-and-error inefficiencies that inflate health care costs and undermine patient care. © 2022, Isfahan University of Medical Sciences(IUMS). All rights reserved.
Related Docs
View other Related Docs
1. Absence of Association Between -1131T>C Polymorphism in the Apolipoprotein Apoa5 Gene and Pediatric Metabolic Syndrome, Iranian Journal of Pediatrics (2014)
2. Transcription Factor 7-Like 2 Polymorphism and Context-Specific Risk of Metabolic Syndrome, Type 2 Diabetes, and Dyslipidemia, Journal of Research in Medical Sciences (2017)
3. Is the Association Between Vitamin D and Metabolic Syndrome Independent of Other Micronutrients?, International Journal for Vitamin and Nutrition Research (2015)
4. Is Frequency of Potato and White Rice Consumption Associated With Cardiometabolic Risk Factors in Children and Adolescents: The Caspian-V Study, BMC Cardiovascular Disorders (2020)
5. Skin and Metabolic Syndrome: A Review of the Possible Associations, Journal of Research in Medical Sciences (2021)
6. Association Between Heme Oxygenase-1 Gene Promoter Polymorphisms and Metabolic Syndrome in Iranians, Molecular Biology Reports (2012)
7. Correlation Between Resistin Level and Metabolic Syndrome Component: A Review, Hormone and Metabolic Research (2018)
8. First-Degree Relatives of Patients With Type 2 Diabetes Mellitus and Risk of Non-Alcoholic Fatty Liver Disease, Review of Diabetic Studies (2007)
Experts (# of related papers)
View all Related Experts
Nizal Sarrafzadegan (15)
Roya Kelishadi (10)
Other Related Docs
9. Association of Dietary Pattern and Metabolic Syndrome in 15- to 49-Years-Old Women, Journal of Isfahan Medical School (2015)
10. Association Analysis of Rs1049255 and Rs4673 Transitions in P22phox Gene With Coronary Artery Disease: A Case-Control Study and a Computational Analysis, Irish Journal of Medical Science (2017)
11. Genome-Wide Analysis in Over 1 Million Individuals of European Ancestry Yields Improved Polygenic Risk Scores for Blood Pressure Traits, Nature Genetics (2024)
12. Incidence of Metabolic Syndrome and Its Risk Factors Among Type 2 Diabetes Clinic Attenders in Isfahan, Iran, Endokrynologia Polska (2012)
13. Metabolic Syndrome in First Degree Relatives of Patients With Type 2 Diabetes: Incidence and Risk Factors, Diabetes and Metabolic Syndrome: Clinical Research and Reviews (2011)
14. Diabetic Cardiomyopathy: 2023 Update by the International Multidisciplinary Board of Experts, Current Problems in Cardiology (2024)
15. Risk of Diabetes According to the Metabolic Health Status and Degree of Obesity, Diabetes and Metabolic Syndrome: Clinical Research and Reviews (2017)
16. Genome-Wide Association Analysis Identifies Novel Blood Pressure Loci and Offers Biological Insights Into Cardiovascular Risk, Nature Genetics (2017)
17. Cardiovascular Disease and Cancer: Evidence for Shared Disease Pathways and Pharmacologic Prevention, Atherosclerosis (2017)
18. Dietary Acid Load Adopts the Effect of Apob Ins/Del Genetic Variant (Rs11279109) on Obesity Trait, Cardiovascular Markers, Lipid Profile, and Serum Leptin Level Among Patients With Diabetes: A Cross-Sectional Study, Scientific Reports (2024)
19. A Personalised Diet Study: The Interaction Between Apoa2 −265T > C Polymorphism and Dietary Inflammatory Index on Oxidative and Inflammatory Markers and Lipid Profile in Patients With Type 2 Diabetes Mellitus: A Cross-Sectional Study, International Journal of Clinical Practice (2021)
20. The Effect of Fads2 Gene Rs174583 Polymorphism on Desaturase Activities, Fatty Acid Profile, Insulin Resistance, Biochemical Indices, and Incidence of Type 2 Diabetes, Journal of Research in Medical Sciences (2018)
21. The Epigenetic Overlap Between Obesity and Mood Disorders: A Systematic Review, International Journal of Molecular Sciences (2020)
22. Genome Analyses of >200,000 Individuals Identify 58 Loci for Chronic Inflammation and Highlight Pathways That Link Inflammation and Complex Disorders, American Journal of Human Genetics (2018)
23. First Report on the Validity of a Continuous Metabolic Syndrome Score As an Indicator for Metabolic Syndrome in a National Sample of Paediatric Population - the Caspian-Iii Study, Endokrynologia Polska (2013)
24. Prevalence of Metabolic Syndrome and Its Components in the Iranian Adult Population: A Systematic Review and Meta-Analysis, Iranian Red Crescent Medical Journal (2015)
25. Comparison of Taqman Real-Time and Tetra-Primer Arms Pcr Techniques for Genotyping of Rs 8066560 Variant in Children and Adolescents With Metabolic Syndrome, Advances in Clinical and Experimental Medicine (2015)
26. Correlation of Circulating Inflammatory Markers, Ghrelin, Adiponectin With Obesity Indices in Subjects With Metabolic Syndrome, Pakistan Journal of Medical Sciences (2013)
27. Interaction Between Cetp Polymorphism and Dietary Insulin Index and Load in Relation to Cardiovascular Risk Factors in Diabetic Adults, Scientific Reports (2021)
28. Association of Polymorphism of Ser311cys Paraoxonase-2 Gene With Type 2 Diabetes Mellitus in Iran, International Journal of Preventive Medicine (2013)
29. Interactions of Dietary Insulin Index and Dietary Insulin Load With Brain-Derived Neurotrophic Factor (Bdnf) Val66met Polymorphism in Relation to Cardiometabolic Markers in Iranian Diabetic Patients: A Cross-Sectional Study, British Journal of Nutrition (2022)
30. Dexamethasone Stress Test: A Pilot Clinical Study for Identification of Individuals Highly Prone to Develop Type 2 Diabetes, Endocrine Practice (2018)
31. Genetics of Familial Combined Hyperlipidemia (Fchl) Disorder: An Update, Biochemical Genetics (2022)
32. Association Between Rs619586 (A/G) Polymorphism in the Gene Encoding Lncrna-Malat1 With Type 2 Diabetes Susceptibility Among the Isfahan Population in Iran, International Journal of Diabetes in Developing Countries (2022)
33. Transcription Factor 7-Like 2 (Tcf7l2) Gene Polymorphism Rs7903146 Is Associated With Lipid Profile and Risk of Cardiovascular Disease Inmetabolic Syndrome Subjects, Journal of Biology and Today's World (2016)
34. Metabolic Syndrome Components and Long-Term Incidence of Cardiovascular Disease in Eastern Mediterranean Region: A 13-Year Population-Based Cohort Study, Metabolic Syndrome and Related Disorders (2019)
35. Whole Exome Sequencing and Whole Genome Sequencing for Investigation of the Genetic Basis of Obesity: A Rapid Review, Bahrain Medical Bulletin (2023)
36. Large-Scale Multi-Omics Studies Provide New Insights Into Blood Pressure Regulation, International Journal of Molecular Sciences (2022)
37. Circulating Advanced Oxidation Protein Products (Aopps) Increases the Risk of Metabolic Syndrome Among Adults: A Systematic Review and Meta-Analysis, International Journal of Diabetes in Developing Countries (2023)
38. The Beneficial Effects of Crocin Supplementation on Metabolic and Genetic Parameters in Type 2 Diabetic Patients Under Metformin Treatment: A Randomized Double-Blind Controlled Clinical Trial, Journal of Functional Foods (2024)
39. Interaction Between Cetp Taq1b Polymorphism and Hei, Dqi and Dpi on Metabolic Biomarkers in Patients With Type 2 Diabetes, Journal of Human Nutrition and Dietetics (2022)
40. Apopulation-Based Metabolic Syndrome Risk Score and Its Determinants: The Isfahan Healthy Heart Program, Journal of Research in Medical Sciences (2014)
41. Association of Rbp4 Gene Variants With Adverse Lipid Profile and Obesity, Gene (2015)
42. Common Gene Polymorphism in Atp-Binding Cassette Transporter A1 and Coronary Artery Disease: A Genetic Association Study and a Structural Analysis, Journal of Cellular Biochemistry (2020)
43. Genetic Determinants of Serum Calcification Propensity and Cardiovascular Outcomes in the General Population, Frontiers in Cardiovascular Medicine (2021)
44. Consumption of Energy-Dense Diets in Relation to Metabolic Syndrome and Inflammatory Markers in Iranian Female Nurses, Public Health Nutrition (2017)
45. Sex Based Pharmacological Treatment in Patients With Metabolic Syndrome: Findings From the Isfahan Healthy Heart Program, African Journal of Pharmacy and Pharmacology (2011)
46. Empirically Derived Dietary Patterns and Incident Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis on Prospective Observational Studies, Public Health Nutrition (2016)
47. Metabolic Syndrome in Type 2 Diabetes Mellitus in Isfahan, Iran: Prevalence and Risk Factors, Metabolic Syndrome and Related Disorders (2007)
48. Comparison of Metabolic Syndrome With Glucose Measurement for Prediction of Type 2 Diabetes: The Isfahan Diabetes Prevention Study, Diabetes and Metabolic Syndrome: Clinical Research and Reviews (2009)
49. Effect of Single Nucleotide Polymorphisms in Seps1 and Sepp1 on Expression in the Protein Level in Metabolic Syndrome in Subjects With Cardiovascular Disease, Molecular Biology Reports (2019)
50. Is the Neutrophil-To-Lymphocyte Ratio an Exceptional Indicator for Metabolic Syndrome Disease and Outcomes?, Endocrine Practice (2022)